PharmaSwiss
 

 

 

Current Capabilities

State-of-the-Art EU, GMP facility

  • Encapsulation for primary and secondary packaging of solid dosage forms.

  • Capacity: 20 MM finished pack per year.

  • Secondary packaging of injectable oncology products, beta lactams and steroids in dedicated space. Separated from main manufacturing area.

  • Located in Belgrade, built in 2005 operations started in 2006.

  • EU GMP approval obtained in June 2007, renewed in June 2010.

 

ü  Supply base due to increasing demand for PharmaSwiss products for sales in Serbia 2006, and for other PharmaSwiss markets from 2009.

ü  Logistic flexibility for small volume and special PharmaSwiss products

 

Planned Capabilities

PharmaSwiss – Regional Leader in Solid Dosage Forms

  • Greenfield investment, located in Belgrade.
  • Project started in Q4 2009.  Site purchased in 2009.  Ground-breaking scheduled for Spring, 2011, start of operations planned for 2012.
  • Production of solid dosage forms, tablets and capsules: weighing, granulation, blending, tablet pressing, coating, encapsulation and blister packaging.
  • Projected capacity: 1 billion bulk units / 50 MM finished packs per year.
  • Secondary packaging of oncology products, beta lactams and steroids in dedicated space. Separated from main manufacturing area.
  • R&D department for development and up-scaling.
  • QC with own laboratory.
  • Warehouse with logistic centre.
 

ü  Qualifies for treatment under Serbian reimbursement as “domestic product”.

ü  Assures earlier launch of new products.

ü  Improves control and flexibility in supply chain.

ü  Improves cost structure.

ü  Enables enhanced competitiveness for PharmaSwiss brands in longer term period.